JOHN CAREY: Open Payments
NPI 1346235561 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,878 in 84 payments from 20 companies in 2025. Trend: 2023 $1,261 · 2024 $1,162 · 2025 $1,878
Food & beverage: $1,878
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $411 |
| Regeneron Healthcare Solutions, Inc. | 9 | $187 |
| GENZYME CORPORATION | 6 | $162 |
| Actelion Pharmaceuticals US, Inc. | 9 | $159 |
| Insmed, Inc. | 6 | $130 |
| Grifols USA, LLC | 6 | $127 |
| INTUITIVE SURGICAL, INC. | 1 | $120 |
| GlaxoSmithKline, LLC. | 6 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
| Verona Pharma, Inc. | 3 | $72 |
Products named: DUPIXENT, TEZSPIRE, OPSUMIT, Arikayce, Da Vinci Surgical System, Prolastin-C Liquid, FASENRA, Ohtuvayre.
Industry payments across GA — which companies pay providers there.
